Difficulty: Medium
Average Score: 62%
Practice
What is the recommended intervention for a neonate with a patent ductus arteriosus who is experiencing respiratory distress?
Correct answer
B
Rationale
In the case of a neonate with a patent ductus arteriosus (PDA) experiencing respiratory distress, the recommended intervention is administering prostaglandin inhibitors (Option B). This is because prostaglandin inhibitors help to promote closure of the PDA, which is essential in improving respiratory function and preventing complications associated with the condition.
Administering oxygen therapy (Option A) may provide temporary relief for respiratory distress symptoms but does not address the underlying cause of the issue, which is the patent ductus arteriosus. Performing a blood transfusion (Option C) is not the primary intervention for a neonate with a PDA and respiratory distress unless there are specific indications for it. Starting positive pressure ventilation (Option D) may be necessary in severe cases of respiratory distress but does not target the PDA itself.
In the educational context, understanding the appropriate interventions for neonates with respiratory distress due to conditions like PDA is crucial for pediatric nurses. Prostaglandin inhibitors play a key role in managing PDA-related respiratory issues, and knowing when and how to administer them can significantly impact patient outcomes in neonatal care.
Administering oxygen therapy (Option A) may provide temporary relief for respiratory distress symptoms but does not address the underlying cause of the issue, which is the patent ductus arteriosus. Performing a blood transfusion (Option C) is not the primary intervention for a neonate with a PDA and respiratory distress unless there are specific indications for it. Starting positive pressure ventilation (Option D) may be necessary in severe cases of respiratory distress but does not target the PDA itself.
In the educational context, understanding the appropriate interventions for neonates with respiratory distress due to conditions like PDA is crucial for pediatric nurses. Prostaglandin inhibitors play a key role in managing PDA-related respiratory issues, and knowing when and how to administer them can significantly impact patient outcomes in neonatal care.